Department of Oncology, University of Lausanne, 1066 Epalinges, Switzerland.
SIB Swiss Institute of Bioinformatics, Bioinformatics Core Facility, 1015 Lausanne, Switzerland.
Immunity. 2020 Nov 17;53(5):985-1000.e11. doi: 10.1016/j.immuni.2020.09.005. Epub 2020 Oct 30.
Central memory CD8 T cells (Tcm) control systemic secondary infections and can protect from chronic infection and cancer as a result of their stem-cell-like capacity to expand, differentiate, and self-renew. Central memory is generally thought to emerge following pathogen clearance and to form based on the de-differentiation of cytolytic effector cells. Here, we uncovered rare effector-phase CD8 T cells expressing high amounts of the transcription factor Tcf7 (Tcf1) that showed no evidence of prior cytolytic differentiation and that displayed key hallmarks of Tcm cells. These effector-phase Tcf7 cells quantitatively yielded Tcm cells based on lineage tracing. Mechanistically, Tcf1 counteracted the differentiation of Tcf7 cells and sustained the expression of conserved adult stem-cell genes that were critical for CD8 T cell stemness. The discovery of stem-cell-like CD8 T cells during the effector response to acute infection provides an opportunity to optimize Tcm cell formation by vaccination.
中央记忆性 CD8 T 细胞(Tcm)可控制全身二次感染,并由于其具有类似于干细胞的扩增、分化和自我更新能力,从而可以预防慢性感染和癌症。通常认为,中央记忆是在清除病原体后出现的,并基于细胞毒性效应细胞的去分化而形成。在这里,我们发现了表达转录因子 Tcf7(Tcf1)的罕见效应期 CD8 T 细胞,这些细胞大量表达 Tcf7,没有细胞毒性分化的证据,并且表现出 Tcm 细胞的关键特征。这些效应期 Tcf7 细胞基于谱系追踪定量产生 Tcm 细胞。从机制上讲,Tcf1 抑制了 Tcf7 细胞的分化,并维持了保守的成年干细胞基因的表达,这些基因对 CD8 T 细胞的干性至关重要。在急性感染的效应反应期间发现具有干细胞样特性的 CD8 T 细胞,为通过疫苗接种优化 Tcm 细胞形成提供了机会。